Our study identified several significant clinicopathological factors associated with recurrence and death, including higher BMI, BRCA1-positivity, preoperative NAC, positive ALND in total mastectomy, non-HRT after surgery, larger tumor size, poor histological grade, PR-negativity, and high Ki-67 expression. This evidence concerns the gene BRCA1 and neoplasm.